CHANGE IN CONTROL SEVERANCE
AGREEMENT
This Change in
Control Severance Agreement (this “ Agreement
”), effective as of
,
, is between American Medical Systems Holdings, Inc., a Delaware
corporation (“Parent Corporation”), on its behalf and
on behalf of all of its Affiliates (collectively, and if the
context requires, each individually, referred to herein as the
“ Company ”), located at 10700 Bren Road West,
Minnetonka, Minnesota 55343 and
, an individual residing at
(the “ Executive ”).
A. The
Executive is currently employed by the Company in an executive or
senior management position.
B. The Board
considers the operation of the Company to be of critical importance
to the Parent Corporation and therefore the establishment and
maintenance of a sound and vital management team of the Company is
essential to protecting and enhancing the best interests of the
Parent Corporation and its stockholders.
C. In this
connection, the Board recognizes that the possibility of a Change
in Control may arise and that such possibility and the uncertainty
and questions which such transaction may raise among key management
personnel of the Company and its subsidiaries could result in the
departure or distraction of such management personnel to the
detriment of the Parent Corporation and its
stockholders.
D. The Board
has determined that appropriate steps should be taken to minimize
the risk that Company executive management will depart prior to a
Change in Control, thereby leaving the Company without adequate
executive management personnel during such a critical period, and
to reinforce and encourage the continued attention and dedication
of members of the Company’s executive management to their
assigned duties without distraction in circumstances arising from
the possibility of a Change in Control.
E. The Board
recognizes that continuance of the Executive’s position with
the Company involves a substantial commitment to the Company in
terms of the Executive’s personal life and professional
career and the possibility of foregoing present and future career
opportunities, for which the Company receives substantial
benefits.
F. To induce
the Executive to remain in the employ of the Company, this
Agreement, which has been approved by the Board, sets forth the
benefits that the Company agrees will be provided to the Executive
in the event of a Change in Control under the circumstances
described below.
G. The
Company and the Executive intend that the benefits provided under
this Agreement will comply, in form and operation, with the
requirements of Section 409A of the Code and this Agreement
will be construed and administered in a manner that is consistent
with and gives effect to such intention.
H. Certain
capitalized terms that are used in this Agreement are defined in
Exhibit A, which is an integral part of this
Agreement.
Accordingly, the
Company and the Executive each intending to be legally bound, agree
as follows:
1. Term
of Agreement . This Agreement is effective immediately and will
continue in effect only so long as the Executive remains employed
by the Company. This Agreement will automatically terminate upon
the Executive’s Termination of Employment with the Company,
except for a Termination of Employment contemplated by
Section 2, in which case this Agreement will remain in effect
until the date on which the Company’s obligations to the
Executive arising under or in connection with this Agreement have
been satisfied in full. Notwithstanding the foregoing, this
Agreement shall terminate immediately (and no benefit will be
payable under this Agreement) in the event, prior to a Change in
Control, and in a transaction that is not a Change in Control,
either the Company ceases to be an Affiliate of the Parent
Corporation or sells all or substantially all of its assets, in one
or a series of related transactions, to any Person.
2.
Benefits upon a Change in Control Termination . The
Executive will become entitled to the benefits described in this
Section 2 on account of a Termination of Employment if and
only if (i) the Company terminates the Executive’s
employment for any reason other than for Cause, or the Executive
terminates the Executive’s employment with the Company for
Good Reason, and (ii) the Termination of Employment occurs
either within the period beginning on the date of a Change in
Control and ending on the last day of the first full calendar month
following the first anniversary date of the Change in Control or
prior to a Change in Control if the Executive’s Termination
of Employment was either a condition of the Change in Control or
was at the request or insistence of a Person related to the Change
in Control.
(a) Cash
Payment . Subject to Section 2(d), not more than
10 days following the Date of Termination, or, if later, not
more than 10 days following the date of the Change in Control,
the Company will make a lump-sum cash payment to the Executive in
an amount equal to [CEO: two times; COO and CFO: one and one-half
times; other executives: one times] the sum of (i) the
Executive’s Base Pay, plus (ii) 100% of the
Executive’s target bonus established for the year during
which the Change in Control occurs.
(b) Group
Health Plans; Life Insurance . If the Executive elects COBRA
coverage under the Company’s group health and dental plans,
then during each month of the Continuation Period (as defined
below), the Company will pay the Executive an amount equal to the
excess of (a) the portion of the monthly cost for the
Executive’s coverage under the Company’s group health
and dental plans that was borne by the Company immediately prior to
the Executive’s Termination of Employment or, if greater,
immediately prior to the Change in Control over (b) the
portion of the monthly cost for the Executive’s coverage
under the Company’s group health and dental plans that is
borne by the Company during the Continuation Period, which excess
is $0.00 if the Executive fails to elect or maintain COBRA coverage
during the Continuation Period. The Executive’s coverage will
be deemed to include any Company contribution to a Health Savings
Account (or similar arrangement) for the Executive. If the level of
the Executive’s coverage changes during the Continuation
Period, as, for example, from single to family coverage or to no
coverage, the amount will be determined as if the new
2
coverage level
had been the level of coverage in effect immediately prior to the
Termination of Employment or Change in Control, as the case may be.
The Executive shall be entitled to elect health care continuation
coverage under the Company’s group health and dental plans
for up to 12 months beyond the end of the 18-month COBRA
period if he or she has not become eligible to participate as an
employee in a plan of another employer providing group health and
dental benefits to the Executive and the Executive’s eligible
family members and dependents, which plan does not contain any
exclusion or limitation with respect to any pre-existing condition
of the Executive or any eligible family member or dependent who
would otherwise be covered under the Company’s plan but for
this clause. If COBRA continuation coverage is not available to the
Executive during any portion of the Continuation Period (other than
by reason of his or her failure to elect COBRA continuation
coverage or to pay the required premiums for such coverage), the
Company will provide comparable medical benefits pursuant to an
alternative arrangement, such as an individual medical insurance
contract, and such alternative benefits will be treated as part of
the Company’s health and dental plan. In addition, during
each month of the Continuation Period, the Executive shall be
entitled to receive life insurance coverage substantially
equivalent to the coverage Executive had on the day immediately
prior to his or her Termination of Employment, including coverage
then in effect for Executive’s spouse and dependents.
Executive shall be required to pay no more for such life insurance
than Executive paid as an active employee immediately before his or
her Termination of Employment. In order to continue life insurance
coverage, Executive must timely elect continuation or the
portability option available under the Company’s group life
insurance policy or policies and pay the full premium for such
coverage following Termination of Employment. The Company will
reimburse Executive at least quarterly for the amount by which such
life insurance premium exceeds the amount Executive paid for such
coverage as an active employee immediately prior to his or her
Termination of Employment.
For purposes of
this section, the “ Continuation Period ” is the
period beginning on the Executive’s Date of Termination and
ending on (x) the last day of the 12th month that begins after
the Executive’s Date of Termination or, if earlier,
(y) the date after the Executive’s Date of Termination
on which the Executive first becomes eligible to participate as an
employee in a plan of another employer providing group health and
dental benefits to the Executive and the Executive’s eligible
family members and dependents, which plan does not contain any
exclusion or limitation with respect to any pre-existing condition
of the Executive or any eligible family member or dependent who
would otherwise be covered under the Company’s plan but for
this clause (y).
(c) To the extent
the Executive incurs a tax liability (including federal, state and
local taxes and any interest and penalties with respect thereto) in
connection with a benefit provided pursuant to Section 2(b) which
the Executive would not have incurred had the Executive been an
active employee of the Company participating in the Company’s
group health and dental plans, the Company will make a payment to
the Executive in an amount equal to such tax liability plus an
additional amount sufficient to permit the Executive to retain a
net amount after all taxes (including penalties and interest) equal
to the initial tax liability in connection with the benefit. For
purposes of applying the foregoing, the Executive’s tax rate
will be deemed to be the highest statutory
3
marginal state
and federal tax rate (on a combined basis) then in effect. The
payment pursuant to this Section 2(b) will be made within
10 days after the Executive’s remittal of a written
request for payment accompanied by a statement indicating the basis
for and amount of the liability, but in no event later than
December 31 of the calendar year to which the tax liability
relates.
(d)
Notwithstanding the foregoing, if, and to the extent, the payments
under Paragraph (a), (b) and/or (c) are considered
deferred compensation that is subject to the requirements of
Section 409A of the Code and, at the time of his or her
Termination of Employment the Executive is a Specified Employee,
then any payment of such benefit(s) shall be suspended and not made
until the first day after the end of the six (6) month period
following the Executive’s Termination of Employment, or, if
earlier, upon the Executive’s death. If any such suspended
payment is not made within 10 days of the end of such six
month period, the Company will pay the Executive interest, as
determined under Section 7(l), from the date of Termination of
Employment through the date of payment.
3. Stock
Option Acceleration . If a Change in Control occurs, regardless
of whether the acquiring entity or Successor assumes or replaces
the stock options or stock awards granted under any Benefit Plan
and then held by the Executive and regardless of whether the
Executive continues to be employed by the Company after the Change
in Control, then all such stock options or stock awards which are
unvested or restricted shall vest and be immediately exercisable in
full, or become unrestricted, as the case may be, as of the date of
the Change in Control and, notwithstanding the provisions of any
Benefit Plan, shall, in the case of options, remain exercisable
until two years after the date of the Change in Control or the date
of the Executive’s Termination of Employment with the
Company, whichever is later, but in no event after the expiration
date of any stock option.
4.
Gross-Up Payments . If the Executive becomes entitled to
payments and benefits in following a Change in Control under
Section 2 or the vesting of any stock options accelerate
following a Change in Control under Section 3, any stock
option agreement or certificate or otherwise, the Company will
cause its independent auditors promptly to review, at the
Company’s sole expense, the applicability of Code
Section 4999 to any payment or distribution of any type by the
Company to or for the Executive’s benefit, whether paid or
payable or distributed or distributable pursuant to the terms of
this Agreement, any stock option agreement or certificate or
otherwise (the “ Total Payments ”). If the
auditor determines that the Total Payments result in an excise tax
imposed on the Executive by Code Section 4999 or any
comparable state or local law, or any interest or penalties with
respect to such excise tax (such excise tax, together with any such
interest and penalties, are collectively referred to as the “
Excise Tax ”), the Company will make an additional
cash payment (a “ Gross-Up Payment ”) to the
Executive within 10 days after such determination equal to an
amount such that after payment by the Executive of all taxes
(including any interest or penalties imposed with respect to such
taxes), including any Excise Tax, imposed upon the Gross-Up
Payment, the Executive would retain an amount of the Gross-Up
Payment equal to the Excise Tax imposed upon the Total Payments.
For purposes of the foregoing determination, the Executive’s
tax rate will be deemed to be the highest statutory marginal state
and federal tax rate (on a combined basis) then in effect. If no
determination by the Company’s auditors is made prior to the
time the Executive
4
is required to
file a tax return reflecting the Total Payments, the Executive will
be entitled to receive from the Company a Gross-Up Payment
calculated on the basis of the Excise Tax the Executive reported in
such tax return, within 10 days after the later of the date on
which the Executive files such tax return or the date on which the
Executive provides a copy thereof to the Company. In all events, if
any tax authority determines that a greater Excise Tax should be
imposed upon the Total Payments than is determined by the
Company’s independent auditors or reflected in the
Executive’s tax return pursuant to this Section 4, the
Executive will be entitled to receive from the Company the full
Gross-Up Payment calculated on the basis of the amount of Excise
Tax determined to be payable by such tax authority within
10 days after the Executive notifies the Company of such
determination. Notwithstanding the foregoing, in the event the
Company reasonably determines that the Gross-Up Payment is subject
to the requirements of Section 409A of the Code, such payment will
be made in the same calendar year in which the Total Payments are
made, provided, however, if the Executive is a Specified Employee,
then any such Gross-up Payment shall be suspended and not made
until the first day after the end of the six (6) month period
following the Executive’s Termination of Employment, or, if
earlier, upon the Executive’s death. The suspended payment
will include interest under Section 7(l) if and only to the extent
such interest is not treated as part of the “Total
Payments.”
5.
Indemnification . Following a Change in Control, the Company
will indemnify and advance expenses to the Executive for damages,
costs and expenses (including, without limitation, judgments,
fines, penalties, settlements and reasonable fees and expenses of
the Executive’s counsel) (the “Expenses”)
incurred in connection with all matters, events and transactions
relating to the Executive’s service to or status with the
Company or any other corporation, employee benefit plan or other
Person for which the Executive served at the request of the Company
to the extent that the Company would have been required to do so
under applicable law, corporate articles, bylaws or agreements or
instruments of any nature with or covering the Executive, including
any indemnification agreement between Parent Corporation and the
Executive, as in effect immediately prior to the Change in Control
and to any further extent as may be determined or agreed upon
following the Change in Control. Any payment required under this
Section 5 will be made no later than March 15 of the
calendar year following the calendar year during which the
liability to indemnify the Expense arises.
6.
Restrictions on Competitive Activities . The Executive
acknowledges that the agreements and covenants contained in this
Section 6 are essential to protect the value of the
Company’s business and assets and by his or her current
employment with the Company, the Executive has obtained and will
obtain such knowledge, contacts, know-how, training and experience
and there is a substantial probability that such knowledge,
know-how, contacts, training and experience could be used to the
substantial advantage of a competitor of the Company and to the
Company’s substantial detriment. In consideration of the
foregoing and the other covenants and agreements of the Company set
forth herein, the Executive agrees to the restrictions contained in
this Section 6.
(a)
Non-Solicitation . The Executive agrees that the Executive
will not, during the Executive’s employment with the Company
and for a period of two years following the date of the
Executive’s voluntary or the Company’s involuntary
termination of the Executive’s employment with the Company
(the “ Restrictive Period ”), directly or
indirectly solicit, or assist anyone else in the solicitation of,
any of the Company’s
5
employees, or
former employees who worked for the Company for the purpose of
hiring them, engaging them as consultants, or inducing them to
leave their employment with the Company. If the Executive is
approached by one of the Company’s employees or former
employees regarding potential employment, consultation or contract,
as described above during the Restrictive Period of
non-solicitation, the Executive must immediately (i) fully
inform the employee or former employee of the Executive’s
non-solicitation obligation described above; and (ii) refrain
from engaging in any communication with the employee or former
employee regarding potential employment, consultation or
contract.
(b) “
Company Product ” means any product, product line or
service that has been designed, developed, manufactured, marketed,
sold or is under research, development, or is being pursued through
acquisition or licensure, or has been the subject of disclosure to
the Company in response to a due diligence process by the Company,
at any time during the Executive’s employment with the
Company; provided, however, that if the Executive becomes entitled
to the benefits described in Section 2 of this Agreement, then
the definition of “Company Product” shall mean Company
Product as of immediately prior to the Change of
Control.
(c) “
Competitive Product ” means goods, products, product
lines or services developed, designed, manufactured, marketed,
promoted, sold, serviced, or that are in development or the subject
of research by any Person that are the same or similar, perform any
of the same or similar functions, may be substituted for, or are
intended or used for any of the same purposes as a Company
Product.
(d) “
Conflicting Organization ” means any Person (including
the Executive), and any parent, subsidiary, partner or affiliate of
any Person, that engages in, or is about to become engaged in, the
development, design, production, manufacture, promotion, marketing,
sale, support or service of a Competitive Product.
(e)
Non-Competition . The Executive agrees that the Executive
will not, during the Restrictive Period, alone or in any capacity
with another Person (e.g., as an advisor, consultant, principal,
agent, partner, officer, director, shareholder, employee or
otherwise), within any geographic area where the Company does
business:
(i) directly or
indirectly disclose to a Conflicting Organization the names or any
other inform
|